alacepril has been researched along with Goldblatt Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, M; Hosoki, K; Matsumoto, K; Miyazaki, H; Nambu, K; Takeyama, K | 1 |
| Fukuya, F; Hosoki, K; Kadokawa, T; Kawahara, S; Minato, H; Takeyama, K | 1 |
| Hatano, N; Hosoki, K; Kadokawa, T; Minato, H; Nakatsuji, K; Nose, I; Oka, M; Suzuki, H; Takeyama, K | 1 |
3 other study(ies) available for alacepril and Goldblatt Syndrome
| Article | Year |
|---|---|
Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Captopril; Hypertension, Renovascular; Kidney; Lung; Male; Rats; Rats, Inbred Strains | 1986 |
Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Angiotensin I; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Captopril; Dinoprostone; Dogs; Hypertension; Hypertension, Renovascular; Kallikreins; Male; Peptidyl-Dipeptidase A; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Water-Electrolyte Balance | 1986 |
Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiac Output; Cerebrovascular Circulation; Dogs; Female; Glomerular Filtration Rate; Hemodynamics; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Renal Circulation; Stroke Volume; Water-Electrolyte Balance | 1986 |